Cohort (N = 40) | Thromboembolic event | ||||||
---|---|---|---|---|---|---|---|
Yes (N = 23) | No (N = 17) | ||||||
Median | [IQR] | Median | [IQR] | Median | [IQR] | p value | |
Laboratory variables (normal values) | |||||||
Haemoglobin (12·5–17·2 g/dL) | 10.1 | [8.5–11.2] | 9.70 | [8.3–10.8] | 10.4 | [9.3–11.9] | ns |
White blood cells (3·5–10·5/nl) | 10.13 | [7.5–13.7] | 10.63 | [7.4–16] | 9.58 | [6.6–12.1] | ns |
Platelet count (150–370/nl) | 193.5 | [131.3–316.3] | 181 | [116–306] | 209 | [178–325.5] | ns |
Prothrombin time (70–130%) | 74.5 | [62.8–86] | 79 | [61–83] | 71 | [63.5–87.5] | ns |
INR (0·9–1·25) | 1.2 | [1.1–1.4] | 1.18 | [1.1–1.4] | 1.26 | [1.1–1.4] | ns |
PTT (26–40 s) | 45.65 | [39.4–56.1] | 51.10 | [40.8–57.4] | 41.1 | [38.7–54.2] | ns |
Fibrinogen (1·6–4 g/l) | 6.67 | [4.7–7.7] | 6.72 | [5.0–7.8] | 6.1 | [4.6–7.9] | ns |
D-dimers (< 0·5 mg/l) | 3.95 | [2.6–5.9] | 4.84 | [3.5–7.2] | 3.06 | [2.3–3.9] | 0.003 |
max. D-dimers (< 0·5 mg/l) | 8.25 | [3.6–16.2] | 11.57 | [8.2–18.4] | 3.98 | [2.6–6.4] | < 0.001 |
Procalcitonin (0·5 µg/l) | 0.57 | [0.2–2.5] | 0.81 | [0.4–4.7] | 0.24 | [0.2–1.3] | ns |
CRP (< 0·5 mg/l) | 123.8 | [84.3–216.5] | 130 | [86–273.7] | 111 | [79.3–185] | ns |
max. CRP (< 0·5 mg/l) | 312.9 | [208.3–343.9] | 341.4 | [261.1–370.7] | 261.05 | [175.3–312.9] | 0.002 |
IL-6 (< 7 ng/l) | 103 | [35·6–230] | 88 | [27.7–340] | 153 | [53.7–206.5] | ns |
max. IL-6 (< 7 ng/l) | 558.6 | [178.8–1792.3] | 550 | [174–2475] | 567.2 | [186.5–1196.5] | ns |
Ferritin (30–400 µg/l) | 1636 | [1067.8–4028.5] | 1663 | [1218.5–4655] | 1567 | [720–3662] | ns |
max. Ferritin (30–400 µg/l) | 2523.2 | [1536.7–6635.1] | 2781.5 | [1854.7–7996.2] | 2028.4 | [922.9–4893.4] | ns |
tPA (2–8 µg/l) | 1 | [0.9–5.5] | 1 | [0.9–3.6] | 2 | [0.9–9.9] | ns |
PAI-1 (7–43 ng/ml) | 36 | [17–70] | 31 | [12–61] | 42.50 | [25.3–87] | ns |
tPA/PAI-1 | 0.053 | [0.02–0.18] | 0.05 | [0.02–0.14] | 11 | [0.03–0.24] | ns |
Antithrombin III (80–120%) | 79 | [58.5–96.5] | 75.5 | [56.8–84] | 94 | [66.5–110] | ns |
Factor VIII (50–150%) | 258 | [190.5–319.5] | 260 | [219.5–355] | 222 | [149.5–289.5] | ns |
Plasminogen (80–120%) | 88 | [72.8–114] | 82 | [72.8–109.8] | 101 | [70.8–129.8] | ns |
ROTEM variables | |||||||
FIBTEM CT (s) | 88.5 | [78–97.8] | 89 | [78–102] | 88 | [75.5–96] | ns |
FIBTEM CFT (s) | 68 | [51–104] | 64.5 | [54–95.8] | 71 | [47–165] | ns |
FIBTEM MCF (mm) | 34.5 | [27.3–39.5] | 35 | [27–38] | 34 | [27–40] | ns |
EXTEM CT (s) | 86 | [69.5–99.8] | 84 | [69–96] | 86 | [70.5–107.5] | ns |
EXTEM CFT (s) | 46.5 | [40–60.5] | 47 | [40–61] | 45 | [40.5–56.5] | ns |
EXTEM MCF (mm) | 75 | [70.3–78] | 75 | [69–78] | 76 | [72.5–78.5] | ns |
INTEM CT (s) | 208 | [181.3–227.5] | 215 | [197–251] | 189 | [171.5–212] | 0.005 |
INTEM CFT (s) | 50.5 | [39.5–61.8] | 56 | [39–63] | 45 | [39.5–60.5] | ns |
INTEM MCF (mm) | 74 | [69–77] | 74 | [65–77] | 73 | [69.5–78] | ns |
HEPTEM CT (s) | 188.5 | [170.5–208.3] | 193 | [173–209] | 173 | [159–206] | ns |
HEPTEM CFT (s) | 41 | [35.5–56.5] | 40 | [34–60] | 42 | [37–51] | ns |
HEPTEM MCF (mm) | 73 | [67.5–75.3] | 73 | [66–76] | 71 | [71–75] | ns |
ML, EXTEM (%) | 3 | [1.3–5.8] | 3 | [0–5] | 5 | [3.5–8] | 0.001 |
ML, INTEM (%) | 3 | [1–6] | 2 | [0–3] | 6 | [2.5–6] | 0.001 |